LeafNLP Demos
Back to explore

Report #2886107

Received Feb 19, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
CA
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (2)

MalaisePalpitations

Symptom narrative

Malaise; Palpitations; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of palpitation in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, less than a day after receiving Shingrix, the patient experienced palpitation (Verbatim: Palpitations) and malaise (Verbatim: Malaise). The patient was treated with paracetamol (Tylenol) and ibuprofen. The outcome of the palpitation was resolved (duration 2 days) and the outcome of the malaise was not resolved. The reporter considered the palpitation and malaise to be related to Shingrix. The company considered the palpitation and malaise to be related to Shingrix. Additional Information: GSK Receipt date: 13-FEB-2026. The patient experienced palpitations on a regular basis during the day following vaccination. The patient did not receive any other vaccines on the day of vaccine administration. The patient also reported experiencing malaise that had lasted through the weekend, but they had expected this to happen. The patient had reported experiencing general malaise following the administration of the first dose of Shingrix. The batch number was not provided and a request for this information has been made.